Active Ingredient(s):Ramelteon FDA Approved: * July 22, 2005 Pharm Company: *TAKEDA GLOBAL Category:Sleep Aid
Ramelteon, sold under the brand name Rozerem among others, is a sleep agent medication that selectively binds to the MT1 and MT2 receptors in the suprachiasmatic nucleus (SCN), instead of binding to GABAA receptors, such as with drugs like zolpidem.
It appears to speed the onset of sleep and alter the total amount of sleep a person gets. It is approved by the US Food and Drug Administration (FDA) for long-term use.
Ramelteon does not show any appreciable ...
* May have multiple approval dates, manufacturers, or labelers. 13 Discussions